Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BBO-10203 |
Trade Name | |
Synonyms | BBO10203|BBO 10203 |
Drug Descriptions |
BBO-10203 binds PIK3CA and disrupts the interaction with RAS, which potentially inhibits downstream signaling and decreases tumor growth (Cancer Res (2024) 84 (9_Supplement): RF02-02). |
DrugClasses | PIK3CA inhibitor 24 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BBO-10203 | BBO-10203 | 0 | 1 |
BBO-10203 + Trastuzumab | BBO-10203 Trastuzumab | 0 | 1 |